Enzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report issued on Wednesday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Down 7.7 %

ENZ opened at $0.50 on Wednesday. Enzo Biochem has a 1 year low of $0.41 and a 1 year high of $1.40. The stock has a 50-day moving average price of $0.68 and a 200-day moving average price of $0.96.

Enzo Biochem (NYSE:ENZ) last issued its earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Hedge Funds Weigh In On Enzo Biochem

Hedge funds have recently bought and sold shares of the business. Virtu Financial LLC purchased a new position in Enzo Biochem in the 4th quarter worth about $35,000. Lepercq De Neuflize Asset Management LLC purchased a new position in Enzo Biochem in the 4th quarter worth about $88,000. BBR Partners LLC purchased a new position in Enzo Biochem in the 3rd quarter worth about $112,000. Wittenberg Investment Management Inc. raised its position in Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock worth $134,000 after buying an additional 70,400 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after purchasing an additional 11,742 shares during the last quarter. Hedge funds and other institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.